Your browser doesn't support javascript.
loading
Safety and Immunogenicity of Adenovirus 35 Tuberculosis Vaccine Candidate in Adults with Active or Previous Tuberculosis. A Randomized Trial.
van Zyl-Smit, Richard N; Esmail, Aliasgar; Bateman, Mary E; Dawson, Rodney; Goldin, Jonathan; van Rikxoort, Eva; Douoguih, Macaya; Pau, Maria Grazia; Sadoff, Jerald C; McClain, J Bruce; Snowden, Margaret Ann; Benko, Jacqueline; Hokey, David A; Rutkowski, Kathryn Tucker; Graves, Andrew; Shepherd, Barbara; Ishmukhamedov, Sadritdin; Kagina, Benjamin M N; Abel, Brian; Hanekom, Willem A; Scriba, Thomas J; Bateman, Eric D.
  • van Zyl-Smit RN; 1 University of Cape Town Lung Institute, Division of Pulmonology, Department of Medicine.
  • Esmail A; 1 University of Cape Town Lung Institute, Division of Pulmonology, Department of Medicine.
  • Bateman ME; 1 University of Cape Town Lung Institute, Division of Pulmonology, Department of Medicine.
  • Dawson R; 1 University of Cape Town Lung Institute, Division of Pulmonology, Department of Medicine.
  • Goldin J; 2 UCLA Medical Centre, Los Angeles, California.
  • van Rikxoort E; 3 Department of Radiology, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands.
  • Douoguih M; 4 Crucell Holland B.V., a Janssen Pharmaceutical company of Johnson & Johnson, Leiden, the Netherlands.
  • Pau MG; 4 Crucell Holland B.V., a Janssen Pharmaceutical company of Johnson & Johnson, Leiden, the Netherlands.
  • Sadoff JC; 4 Crucell Holland B.V., a Janssen Pharmaceutical company of Johnson & Johnson, Leiden, the Netherlands.
  • McClain JB; 5 Aeras, Rockville, Maryland; and.
  • Snowden MA; 5 Aeras, Rockville, Maryland; and.
  • Benko J; 5 Aeras, Rockville, Maryland; and.
  • Hokey DA; 5 Aeras, Rockville, Maryland; and.
  • Rutkowski KT; 5 Aeras, Rockville, Maryland; and.
  • Graves A; 5 Aeras, Rockville, Maryland; and.
  • Shepherd B; 5 Aeras, Rockville, Maryland; and.
  • Ishmukhamedov S; 5 Aeras, Rockville, Maryland; and.
  • Kagina BMN; 6 South African TB Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine, Division of Immunology, Department of Pathology, and.
  • Abel B; 7 Vaccines for Africa Initiative, Division of Medical Microbiology, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa.
  • Hanekom WA; 6 South African TB Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine, Division of Immunology, Department of Pathology, and.
  • Scriba TJ; 8 Singapore Immunology Network, Agency for Science, Technology and Research, Singapore.
  • Bateman ED; 6 South African TB Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine, Division of Immunology, Department of Pathology, and.
Am J Respir Crit Care Med ; 195(9): 1171-1180, 2017 05 01.
Article en En | MEDLINE | ID: mdl-28060545
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Tuberculosis Pulmonar / Vacunas contra la Tuberculosis Tipo de estudio: Clinical_trials Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Año: 2017 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Tuberculosis Pulmonar / Vacunas contra la Tuberculosis Tipo de estudio: Clinical_trials Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Año: 2017 Tipo del documento: Article